Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patients.

Abstract

AIMS The aim of this study was to investigate the therapeutic effect of recombinant human erythropoietin (rHuEpo) on anaemia with erythropoietin deficiency in diabetic patients. METHODS Twenty diabetic patients with anaemia and Epo deficiency were enrolled. All patients were treated with rHuEpo (Epokine; 4000 U/day s.c., three times a week) for 8 weeks… (More)

Topics

Cite this paper

@article{Kim2003TherapeuticEO, title={Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patients.}, author={D. J. Kim and Y. M. Kim and Yvette Yun and C. W. Ahn and B. S. Cha and Y. D. Song and S. K. Lim and K. R. Kim and Jochen Hahn and Kyung-Hoe Huh and H. C. Lee}, journal={Diabetic medicine : a journal of the British Diabetic Association}, year={2003}, volume={20 8}, pages={661-4} }